Clinical Evaluation of the CM-1500 During Apheresis Blood Donation

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Fluid Loss
Interventions
DEVICE

CM-1500

The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors five (5) parameters of a patient's body. A combination of these parameters is represented by a single number known as the Relative Index value.

DEVICE

CM-1600

The CM-1500 is a U.S. FDA cleared non-invasive monitoring device that simultaneously monitors Bioelectrical Impedance, Photoplethysmography (PPG) Amplitude, ECG Amplitude and Skin Temperature. A combination of these parameters is represented by a single number known as the Relative Index value.

Trial Locations (1)

80230

Vitalant Blood Donation, Denver

All Listed Sponsors
lead

Zynex Monitoring Solutions

INDUSTRY

NCT05012462 - Clinical Evaluation of the CM-1500 During Apheresis Blood Donation | Biotech Hunter | Biotech Hunter